On Monday, Vaxcyte Inc (NASDAQ: PCVX) opened lower -3.97% from the last session, before settling in for the closing price of $88.32. Price fluctuations for PCVX have ranged from $58.10 to $121.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 5.53% at the time writing. With a float of $120.32 million, this company’s outstanding shares have now reached $124.43 million.
Let’s determine the extent of company efficiency that accounts for 254 employees. In terms of profitability, gross margin is 2.95%, operating margin of -3662.28%, and the pretax margin is -3514.11%.
Vaxcyte Inc (PCVX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vaxcyte Inc is 3.47%, while institutional ownership is 107.90%. The most recent insider transaction that took place on Feb 03 ’25, was worth 705,600. Before that another transaction happened on Jan 21 ’25, when Company’s PRESIDENT AND CFO sold 8,000 for $86.51, making the entire transaction worth $692,101. This insider now owns 109,491 shares in total.
Vaxcyte Inc (PCVX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.81% during the next five years compared to -46.98% drop over the previous five years of trading.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Check out the current performance indicators for Vaxcyte Inc (PCVX). In the past quarter, the stock posted a quick ratio of 17.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.68, a number that is poised to hit -1.11 in the next quarter and is forecasted to reach -4.38 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
Looking closely at Vaxcyte Inc (NASDAQ: PCVX), its last 5-days average volume was 0.94 million, which is a drop from its year-to-date volume of 1.2 million. As of the previous 9 days, the stock’s Stochastic %D was 44.85%. Additionally, its Average True Range was 3.98.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 16.75%, which indicates a significant decrease from 44.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.84% in the past 14 days, which was higher than the 44.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $87.74, while its 200-day Moving Average is $87.31. However, in the short run, Vaxcyte Inc’s stock first resistance to watch stands at $87.09. Second resistance stands at $89.37. The third major resistance level sits at $90.54. If the price goes on to break the first support level at $83.64, it is likely to go to the next support level at $82.47. Now, if the price goes above the second support level, the third support stands at $80.19.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
There are currently 124,637K shares outstanding in the company with a market cap of 10.57 billion. Presently, the company’s annual sales total 0 K according to its annual income of -402,270 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -103,120 K.
